Le Lézard
Classified in: Health, Science and technology
Subject: ACC

Bulletin from the Annual General Meeting 2020


STOCKHOLM, June 30, 2020 /PRNewswire/ -- At the Annual General Meeting of RaySearch Laboratories AB (publ) held today, the following resolutions were adopted.

It was resolved to re-elect Carl Filip Bergendal, Johan Löf, Britta Wallgren, Hans Wigzell, Lars Wollung and Johanna Öberg as board members of the company and to re-elect Lars Wollung as chairman of the board.

The Annual General Meeting adopted the balance sheets and income statements and discharged the members of the board and the CEO from liability. It was resolved that the accumulated profit, amounting to SEK 206,198,000 be brought forward and balanced in the new accounts.

It was resolved to adopt the guidelines for remuneration to senior executives proposed by the board.

It was resolved that remuneration to board members who do not receive a salary from any Group company shall amount to SEK 700,000 to the chairman of the board and SEK 250,000 to each of the other board members elected by the general meeting.

It was resolved that the auditor's fees be paid in accordance with approved invoicing and to re-elect the auditing firm Ernst & Young as auditor.

The Annual General Meeting also approved the board's proposal regarding amendments of the articles of association.

CONTACT:

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46-(0)8-510-530-00
[email protected]

Peter Thysell, CFO, RaySearch Laboratories AB (publ) 
Telephone: +46-(0)70-661-05-59
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/bulletin-from-the-annual-general-meeting-2020,c3145657

The following files are available for download:

https://mb.cision.com/Main/1102/3145657/1272447.pdf

Release

SOURCE RaySearch Laboratories


These press releases may also interest you

at 06:15
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Exciting technical...

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...



News published on and distributed by: